MIMEDX GROUP, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.225 USD | +1.06% |
|
-3.96% | -29.48% |
| Mar. 27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
| Mar. 27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
Presenter SpeechSwayampakula Ramakanth (Analysts)Good morning, and thanks for joining us to ha...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.
Calendar
2024-04-30
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
6.16
USD
Average target price
12.44
USD
Spread / Average Target
+101.89%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -29.48% | 905M | |
| -21.76% | 130M | |
| -18.62% | 59.78M | |
| +0.68% | 58.78M | |
| -2.40% | 50.16M |
- Stock Market
- Equities
- MDXG Stock
- News MiMedx Group, Inc.
- Transcript : MiMedx Group, Inc. Presents at H.C. Wainwright Global Investment Conference 2022, May-24-2022 10
